NEUMORA THERAPEUTICS, INC. (NMRA) ROA
- 2026-06-30: ROA -169.86%.
- 2026-03-31: ROA -144.53%.
- 2025-12-31: ROA -124.02%.
- 2025-09-30: ROA -132.88%.
Complete source-backed roa history.
- Available history
- 2022-12-31 to 2026-06-30
- Data captured
Historical ROA
| Date | ROA |
|---|---|
| 2026-06-30 | -169.86% |
| 2026-03-31 | -144.53% |
| 2025-12-31 | -124.02% |
| 2025-09-30 | -132.88% |
| 2025-06-30 | -112.63% |
| 2025-03-31 | -100.51% |
| 2024-12-31 | -76.91% |
| 2024-09-30 | -83.31% |
| 2024-06-30 | -67.79% |
| 2024-03-31 | -56.42% |
| 2023-12-31 | -47.55% |
| 2023-09-30 | -28.52% |
| 2022-12-31 | -30.71% |
Annual ROA
| Date | ROA |
|---|---|
| 2025-12-31 | -124.02% |
| 2024-12-31 | -76.91% |
| 2023-12-31 | -47.55% |
| 2022-12-31 | -30.71% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |